300 related articles for article (PubMed ID: 29577272)
1. Effect of a tissue selective estrogen complex on breast cancer: Role of unique properties of conjugated equine estrogen.
Yue W; Wang J; Atkins KA; Bottalico L; Mesaros C; Blair IA; Santen RJ
Int J Cancer; 2018 Sep; 143(5):1259-1268. PubMed ID: 29577272
[TBL] [Abstract][Full Text] [Related]
2. Effects of the conjugated equine estrogen/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in mice.
Song Y; Santen RJ; Wang JP; Yue W
Endocrinology; 2012 Dec; 153(12):5706-15. PubMed ID: 23070546
[TBL] [Abstract][Full Text] [Related]
3. Preclinical breast effects of a tissue selective estrogen complex (TSEC) including conjugated estrogen with bazedoxifene.
Santen RJ; Song Y; Wang JP; Yue W
J Steroid Biochem Mol Biol; 2017 Jun; 170():61-64. PubMed ID: 27174719
[TBL] [Abstract][Full Text] [Related]
4. Effects of bazedoxifene acetate with and without conjugated equine estrogens on the breast of postmenopausal monkeys.
Ethun KF; Wood CE; Register TC; Cline JM; Appt SE; Clarkson TB
Menopause; 2012 Nov; 19(11):1242-52. PubMed ID: 23103754
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of a bazedoxifene/conjugated equine estrogen combination on human breast cancer cells in vitro.
Song Y; Santen RJ; Wang JP; Yue W
Endocrinology; 2013 Feb; 154(2):656-65. PubMed ID: 23254198
[TBL] [Abstract][Full Text] [Related]
6. Effects of menopausal hormonal therapy on occult breast tumors.
Santen RJ; Song Y; Yue W; Wang JP; Heitjan DF
J Steroid Biochem Mol Biol; 2013 Sep; 137():150-6. PubMed ID: 23748149
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Experimental Arthritis and Associated Bone Loss by a Tissue-Selective Estrogen Complex.
Andersson A; Bernardi AI; Nurkkala-Karlsson M; Stubelius A; Grahnemo L; Ohlsson C; Carlsten H; Islander U
Endocrinology; 2016 Mar; 157(3):1013-20. PubMed ID: 26745543
[TBL] [Abstract][Full Text] [Related]
8. Endometrial profile of bazedoxifene acetate alone and in combination with conjugated equine estrogens in a primate model.
Ethun KF; Wood CE; Cline JM; Register TC; Appt SE; Clarkson TB
Menopause; 2013 Jul; 20(7):777-84. PubMed ID: 23793168
[TBL] [Abstract][Full Text] [Related]
9. Differential utilization of nuclear and extranuclear receptor signaling pathways in the actions of estrogens, SERMs, and a tissue-selective estrogen complex (TSEC).
Madak-Erdogan Z; Gong P; Katzenellenbogen BS
J Steroid Biochem Mol Biol; 2016 Apr; 158():198-206. PubMed ID: 26689478
[TBL] [Abstract][Full Text] [Related]
10. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
Pickar JH; Komm BS
Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
[TBL] [Abstract][Full Text] [Related]
11. From the Women's Health Initiative to the combination of estrogen and selective estrogen receptor modulators to avoid progestin addition.
Valera MC; Gourdy P; Trémollières F; Arnal JF
Maturitas; 2015 Nov; 82(3):274-7. PubMed ID: 26261036
[TBL] [Abstract][Full Text] [Related]
12. Tissue-selective estrogen complexes for postmenopausal women.
Mirkin S; Komm BS
Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
[TBL] [Abstract][Full Text] [Related]
13. [Third generation selective estrogen receptor modulators: benefits beyond bone. II, endometrial action].
Calaf Alsina J; Coronado Martín PJ
Med Clin (Barc); 2013 Mar; 140(6):266-71. PubMed ID: 23276611
[TBL] [Abstract][Full Text] [Related]
14. Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone?
Falk RT; Manson JE; Barnabei VM; Anderson GL; Brinton LA; Rohan TE; Cauley JA; Chen C; Coburn SB; Pfeiffer RM; Reding KW; Sarto GE; Wentzensen N; Chlebowski RT; Xu X; Trabert B
Int J Cancer; 2019 Feb; 144(4):730-740. PubMed ID: 30183089
[TBL] [Abstract][Full Text] [Related]
15. Effects of bazedoxifene, conjugated equine estrogens, and a tissue-selective estrogen complex containing both bazedoxifene and conjugated equine estrogens on cerebral artery atherosclerosis in postmenopausal monkeys.
Clarkson TB; Ethun KF; Pajewski NM; Golden D; Floyd E; Appt SE
Menopause; 2014 Jan; 21(1):8-14. PubMed ID: 23676638
[TBL] [Abstract][Full Text] [Related]
16. Aprela, a single tablet formulation of bazedoxifene and conjugated equine estrogens (Premarin) for the potential treatment of menopausal symptoms.
Stovall DW
Curr Opin Investig Drugs; 2010 Apr; 11(4):464-71. PubMed ID: 20336595
[TBL] [Abstract][Full Text] [Related]
17. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Parish SJ; Gillespie JA
Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of oral conjugated equine estrogens and micronized 17beta-estradiol on breast proliferation: a retrospective analysis.
Wood CE; Clarkson TB; Chen H; Veenstra TD; Xu X; Scott L; Cline JM
Menopause; 2008; 15(5):890-8. PubMed ID: 18520696
[TBL] [Abstract][Full Text] [Related]
19. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
Zhao L; Brinton RD
BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: insights into the unique antagonistic effects of bazedoxifene on conjugated estrogens.
Chang KC; Wang Y; Bodine PV; Nagpal S; Komm BS
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):117-24. PubMed ID: 19914376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]